623
Views
9
CrossRef citations to date
0
Altmetric
Original Article

In vivo experimental approach to treatment against tabun poisoning

, , , , &
Pages 531-536 | Received 17 Jul 2009, Accepted 22 Sep 2009, Published online: 17 Mar 2010
 

Abstract

Organophosphorus compounds pose a potential threat to both military and civilian populations. Since post-exposure therapy has its limitations, our research was focused on the possibility of improving pretreatment in order to limit the toxic effects of tabun. We determined the protective index of various combinations of atropine, oximes (K074, K048, and TMB-4), and pyridostigmine given to mice before tabun intoxication. Although the tested oximes showed very good therapeutic efficacy in tabun-poisoned mice, the given pretreatments improved therapy against tabun poisoning. These regimens ensured survival of all animals up to 25.2 LD50 of tabun. Our results indicate that even pretreatment with atropine alone is sufficiently effective in enhancing the survival of mice poisoned by multiple doses of tabun, if oxime therapy follows. K048 is our oxime of choice for future research, as it shows better protective and reactivating potency.

Acknowledgements

We wish to thank Jasna Mileković and Marija Kramarić for technical assistance, and Dado Čakalo for helpful language advice.

Declaration of interest

This work was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (Grant No. 022-0222148-2139 and No. 022-0222148-2889) and by NATO (CBP.EAP.CLG 983024).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.